Skip to main content
. 2022 Jul 14;9(8):1241–1251. doi: 10.1002/acn3.51625

Figure 2.

Figure 2

Association between decrease in YKL‐40 CSF levels and improvements in RULM score during treatment with nusinersen. YKL‐40 levels decreased more in patients showing improvements in the RULM score during treatment with nusinersen. The gray zone surrounding the regression line represents the confidence interval. Abbreviations: YKL‐40, chitinase‐3‐like protein 1; CSF, cerebrospinal fluid; RULM, Revised Upper Limb Module.